Articles

How patient-centricity embeds value and stability in LTFU studies

Drug development is evolving. With an increased awareness of how factors such as culture, sex and genetic differences affect how patients respond to therapeutics, new drugs must demonstrate long-term efficacious and safe treatment of the target disease to provide regulatory approval and market access.

Filed In

Articles
Clinical
Commercialization
Oncology